Document Detail


Effects of exposure to benzodiazepine during fetal life.
MedLine Citation:
PMID:  1355799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dysmorphism and mental retardation have been reported in 7 Swedish children born of mothers who had taken high doses of benzodiazepines regularly during pregnancy. To explore this association further, we examined benzodiazepine use during pregnancy in 104,000 women whose deliveries were registered by the US public health insurance system, Medicaid, during 1980-83. Fetal outcomes were assessed from the health claims profiles of their offspring, up to 6-9 years after delivery. 80 pregnant women had received 10 or more benzodiazepine prescriptions during the 4 years. Their records showed heavy general use of health care and frequent alcohol and substance abuse, and other disorders that could confound any effect of the benzodiazepines. For the 80 pregnancies, 3 intrauterine deaths were identified as well as 2 infants with congenital abnormalities whose curtailed records suggested neonatal death. Records of 64 surviving children could be linked to these 80 pregnancies whilst records for 11 apparent survivors could not be located. 6 of the 64 survivors had diagnoses consistent with teratogenic abnormalities. The high rate of teratogenicity after heavy maternal benzodiazepine use occurs with multiple alcohol and substance exposure and thus may not be due to benzodiazepine exposure.
Authors:
U Bergman; F W Rosa; C Baum; B E Wiholm; G A Faich
Related Documents :
18222969 - Fetal learning about ethanol and later ethanol responsiveness: evidence against "safe" ...
17300889 - Effect of infrasound on cochlear damage from exposure to a 4 khz octave band of noise.
8800309 - Acute multifocal skin necrosis: synergism between invasive streptococcal infection and ...
12507969 - Prevalence of fatty acid ethyl esters in meconium specimens.
9366129 - Attitudes and knowledge about drinking: relationships with drinking behavior among preg...
20436309 - Pulmonary imaging during pregnancy.
15511859 - Reversal of female sterilisation experience in a district general hospital.
7936839 - Aminoterminal propeptide of type iii procollagen in cord blood and amniotic fluid of ap...
21069579 - Molecular mechanism of pancreatic β-cell adaptive proliferation: studies during pregna...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Lancet     Volume:  340     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-10-15     Completed Date:  1992-10-15     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  694-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / epidemiology*
Benzodiazepines / adverse effects*
Child
Female
Fetal Alcohol Syndrome / etiology
Fetus / drug effects*
Humans
Infant, Newborn
Maternal-Fetal Exchange
Pregnancy
Substance Withdrawal Syndrome
United States
Chemical
Reg. No./Substance:
12794-10-4/Benzodiazepines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indon...
Next Document:  Stereoselective release of (S)-atenolol from adrenergic nerve endings at exercise.